<DOC>
	<DOC>NCT02727673</DOC>
	<brief_summary>The aim of this study is to establish a platform of detecting and sorting circulating tumor stem cells from peripheral blood in HCC patients; to investigate the relationship between circulating tumor stem cells and their effects on postoperative recurrence and metastasis, in order to provide a new therapeutic target for hepatocellular carcinoma treatment.</brief_summary>
	<brief_title>Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>1. Male or female patients &gt; 18 years and &lt;=70 years of age; 2. No dysfunction in major organs; Blood routine, kidney function, cardiac function and lung function are basically normal. 3. Patients who can understand this trial and have signed information consent 1. Reject to attendï¼› 2. Impossible to come to our hospital for physical examination regularly; 3. Patients with other diseases which may affect the treatment mentioned</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cancer stem cells</keyword>
</DOC>